<DOC>
	<DOCNO>NCT00387283</DOCNO>
	<brief_summary>During clinical study people severe West Nile virus infection , determine drug AVI-4020 cross blood-brain barrier . This study assess amount drug go across blood-brain barrier drug level measure blood urine . The objective study find much fast drug cross barrier .</brief_summary>
	<brief_title>Pharmacokinetic Study Cerebral Spinal Fluid After Single Dose AVI-4020</brief_title>
	<detailed_description>AVI-4020 design interfere West Nile virus translation , show cross blood-brain barrier normal inflamed meninges clinical study patient severe West Nile virus disease . At issue , whether observation limit AVI-4020 PMO drug , observe PMO drug . This study one three ass specific ability PMO drug cross blood-brain barrier , use similar dosing , PK assessment time point . In order rigorously assess pharmacokinetics , study perform healthy volunteer single point time . The ability PMO drug cross blood-brain barrier set stage future study exploit product characteristic .</detailed_description>
	<criteria>Adult males 18 year 64 year age ; Good general health ( evidence chronic condition , normal physical exam , vital sign within normal limit ; laboratory evaluation within normal range ) Signed date write informed consent form ; Willing participate study activity requirement , include effective contraception ( viz. , doublebarrier method ) 7day study surveillance period . Hematology , serum chemistry ( exclusive electrolyte ) , urinalysis laboratory test value &gt; 2 time upper limit normal anemia ( hemoglobulin &lt; 11 g/dL ) , leukopenia ( total white blood count &lt; 3,000/µL total neutrophil &lt; 1,500/ µL ) thrombocytopenia ( platelet &lt; 100,000/µL ) . Electrolytes coagulation value exceed normal range exclude . Body Mass Index ( BMI ) &gt; 35 . Calculated creatinine clearance ( Cockroft Gault Formula ) &lt; 70 mL/min , base age gender . Positive HIV1 HIV2 serology . Positive HCV serology and/or positive plasma HCVRNA status . Positive Hepatitis B status . Solid hematopoetic organ transplant recipient . Active illness recent illness within 30 day first dose study drug . History follow : brain injury , neoplasm , chronic migraine headache , cancer , meningitis hydrocephalus . Usage prescribe , overthecounter illicit drug ( ) within 30 day study drug administration . Use herbal remedy and/or supplement discretion Investigator . Unwilling practice effective contraception study period . Participation clinical interventional trial within previous 6 month . Positive drug urine screen .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>WNV</keyword>
	<keyword>West Nile virus</keyword>
	<keyword>WNV meningoencephalitis</keyword>
</DOC>